Michael T. Selch - Concepedia

Author

Michael T. Selch

Also Known As

M Selch, M T Selch, M. SELCH, M. Selch, M. T. Selch, M.T Selch, M.T. Selch, MICHAEL SELCH, Maximilian Selch, Michael Selch

216

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center University of California, San Francisco UCLA Medical Center Oklahoma State University Center for Health Sciences

About

Michael T. Selch is an author at University of California, Los Angeles specializing in medicine, radiation oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	47	2.1K
2	Health Sciences	20	26	1K
3	Engineering	3	3	92
4	Cellular Therapies	1	1	12
5	Gastroenterology	1	1	10

Michael T. Selch

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Journal of Clinical Oncology	2010	451
Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas Fritz C. Eilber, Gerald Rosen, J J Eckardt, Journal of Clinical Oncology	2001	326
Favorable Biology and Outcome of Stage IV-S Neuroblastoma With Supportive Care or Minimal Therapy: A Children’s Cancer Group Study H. James Nickerson, Katherine K. Matthay, Robert C. Seeger, Journal of Clinical Oncology	2000	283
Treatment of Donor Bone Marrow with Monoclonal Anti-T-Cell Antibody and Complement for the Prevention of Graft-Versus-Host Disease Ronald T. Mitsuyasu, Richard Champlin, Robert Peter Gale, Annals of Internal Medicine	1986	269
High-Grade Extremity Soft Tissue Sarcomas Fritz C. Eilber, Gerald Rosen, Scott D. Nelson, Annals of Surgery	2003	229
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability Albert Lai, Emese Filka, B. McGibbon, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyInterim AnalysisRadiation MedicineRegional Radiation TherapyRadiation Therapy	2008	184
Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study Daphne A. Haas‐Kogan, Patrick S. Swift, Michael T. Selch, International Journal of Radiation OncologyBiologyPhysics Radiation MedicinePediatric Brain TumorsRadiation TherapyMedicinePediatrics	2003	172
SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL Stephen D. Nimer, Janis V. Giorgi, James Gajewski, Transplantation	1994	171
Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A childrens cancer group phase 1/11 trial Roger J. Packer, James M. Boyett, Robert A. Zimmerman, Cancer	1994	164
Treatment of Acute Myelogenous Leukemia Richard E. Champlin, Winston G. Ho, Robert Peter Gale, Annals of Internal Medicine	1985	161

Page 1